Abstract:
Objective To investigate the impact of LINC01234 on the proliferation, invasion, and migration of acute myeloid leukemia (AML) cells by regulating insulin-like growth factor 2 mRNA binding protein 1 (IGF2BP1)/c-Myc expression.
Methods Peripheral blood samples were collected from 31 AML patients and 24 healthy volunteers who underwent physical examination at Enshi Center Hospital from March 2019 to September 2021. The expression pattern of LINC01234 in AML specimens and five cell lines, MV-4-11, NB4, KG-1, THP-1, and HL-60, was analyzed using real-time quantitative PCR (qRT-PCR). HL-60 cells were randomly selected for use in preparing the blank control (BC) group, sh-control group, sh-LINC01234 group, sh-LINC01234+pcDNA-control group, and sh-LINC01234 +pcDNA-c-Myc group. qRT-PCR was performed to measure the expression of LINC01234, IGF2BP1, and c-Myc in the cells. Cell counting kit-8 assay and transwell migration and invasion assay were performed to assess cell proliferation ability and cell migration and invasion, respectively. RNA immunoprecipitation and RNA pull-down experiments were performed to confirm the regulatory relevance of LINC01234, IGF2BP1, and c-Myc in AML cells.
Results LINC01234 expression was higher in AML specimens and the five cell lines than in specimens from healthy volunteers and human bone marrow stromal cells HS-5 (P<0.05). After LINC01234 expression was downregulated by sh-LINC01234 in HL-60 cells, the OD value and the numbers of invasive and migrating cells were significantly reduced (P<0.05). LINC01234 bound to IGF2BP1 and promoted the interaction between IGF2BP1 and c-Myc mRNA, thereby improving the stability of c-Myc mRNA (P<0.05). Overexpression of c-Myc reversed the decrease in proliferation and metastasis of HL-60 cells caused by LINC01234 silencing (P<0.05).
Conclusions LINC01234 is a novel AML-related lncRNA that promotes the stability of c-Myc mRNA by competitively binding to IGF2BP1, thereby promoting proliferation, invasion, and migration of AML cells.